FDA Announces Approval of Information Collection for New Drug Approval Process

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on the evidence needed to demonstrate the effectiveness of new drugs, as required by the Paperwork Reduction Act of 1995.